BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 21, 2011
 |  BC Week In Review  |  Company News  |  Deals

Adventrx, SynthRx Inc. deal

Adventrx will acquire SynthRx in a stock deal valued at up to $35.5 million, based on Adventrx's close of $2.16 on Feb. 11, before the deal was announced, or about $48.1 million based on Adventrx's close of $2.93 on Jan. 6, before the company said it had signed a non-binding term sheet to...

Read the full 243 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >